title: Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD.
authors.forename: François
authors.initials: F
authors.lastname: Maltais
authors.forename: Donald A
authors.initials: DA
authors.lastname: Mahler
authors.forename: Véronique
authors.initials: V
authors.lastname: Pepin
authors.forename: Eric
authors.initials: E
authors.lastname: Nadreau
authors.forename: Glenn D
authors.initials: GD
authors.lastname: Crater
authors.forename: Andrea N
authors.initials: AN
authors.lastname: Morris
authors.forename: Amanda H
authors.initials: AH
authors.lastname: Emmett
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Ferro
mesh_terms: D000368:Aged; D000420:Albuterol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000730:Androstadienes / Q000008:administration & dosage*; D001993:Bronchodilator Agents / Q000008:administration & dosage; D004311:Double-Blind Method; D004338:Drug Combinations; D017079:Exercise Tolerance; D005260:Female; D000068297:Fluticasone-Salmeterol Drug Combination; D005541:Forced Expiratory Volume; D006801:Humans; D008297:Male; D008875:Middle Aged; D010807:Physical Endurance; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D012602:Scopolamine Derivatives / Q000008:administration & dosage*; D013566:Sympathomimetics / Q000008:administration & dosage; D000069447:Tiotropium Bromide; D016896:Treatment Outcome; D016138:Walking
chemical_list: D000730:Androstadienes; D001993:Bronchodilator Agents; D004338:Drug Combinations; D000068297:Fluticasone-Salmeterol Drug Combination; D012602:Scopolamine Derivatives; D013566:Sympathomimetics; D000420:Albuterol; D000069447:Tiotropium Bromide